Hot Warren Buffett Stocks To Invest In 2014

MADRID (MarketWatch) — U.S. stock market futures pointed to a firmer open for Wall Street on Monday, but investors remained wary ahead of key employment figures due later in the week that could be a deciding factor for when the Federal Reserve decides to taper its bond-buying program.

For Monday, factory orders are due, and investors will be scouring a positive piece of data out of China. Kellogg Co. is also due to report ahead of the opening bell.

Click to Play Google's Schmidt on NSA, China and North Korea

On a recent visit to Hong Kong, Google Executive Chairman Eric Schmidt spoke to Deborah Kan about allegations that the U.S. National Security Agency spied on the company’s data centers, censorship in China, and the country he wants to visit next.

Hot Warren Buffett Stocks To Invest In 2014: ICU Medical Inc.(ICUI)

ICU Medical, Inc. engages in the development, manufacture, and sale of medical technologies used in infusion therapy, oncology, and critical care applications. The company?s product line includes custom infusion systems, closed delivery systems for hazardous drugs, needleless infusion connectors, catheters, and cardiac monitoring systems. Its products enhance patient outcomes by preventing bloodstream infections, protecting healthcare workers and patients from exposure to infectious diseases or hazardous drugs, and monitoring the cardiac output of critical care patients. The company offers intravenous (I.V.) therapy lines consisting of a tube running from a bottle or plastic bag containing an I.V. solution to a catheter inserted in a patient?s vein for use in hospitals and ambulatory clinics; CLAVE product, a needleless I.V. connection device, which would be used with conventional peripheral or central vascular access systems for venous and arterial applications; custom in fusion sets. It also provides critical care products that monitor vital signs and specific physiological functions of key organ systems, including disposable pressure-sensing devices, blood sampling systems, angiography kits, sensory catheters, pulmonary artery thermodilution catheters, and multi-lumen central venous catheters. In addition, the company provides TEGO for use in dialysis; a line of oncology products, including Spiros male luer connector device; the Genie vial access device; and custom I.V sets and ancillary products for chemotherapy. ICU Medical, Inc. sells its products to medical product manufacturers and independent medical supply distributors, as well as directly to the end customers worldwide. The company was founded in 1984 and is headquartered in San Clemente, California.

Advisors’ Opinion:

  • [By Sean Williams]

    What: Shares of ICU Medical (NASDAQ: ICUI  )  — a medical device maker in the fields of infusion therapy, oncology, and critical care — soared as much as 17% on a report that the company could be exploring a sale.

  • [By Seth Jayson]

    ICU Medical (Nasdaq: ICUI  ) is expected to report Q2 earnings around July 16. Here’s what Wall Street wants to see:

    The 10-second takeaway
    Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict ICU Medical’s revenues will increase 8.0% and EPS will expand 4.8%.

  • [By CRWE]

    ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, reported that Company management will be presenting at the UBS Global Life Sciences Conference to be held on September 19-20, 2012, at the Grand Hyatt Hotel, New York.

Hot Warren Buffett Stocks To Invest In 2014: MEDIWARE Information Systems Inc.(MEDW)

Mediware Information Systems, Inc., together with its subsidiaries, engages in the design, development, and marketing of software solutions targeting specific processes within healthcare institutions. The company offers software systems consisting of company’s proprietary application software, and third-party licensed software and hardware. It licenses, implements, and supports clinical and performance management, blood donor, and blood and biologic management products in the United States; and medication management solutions in the United States, the United Kingdom, Ireland, and South Africa. The company?s blood and biologics management solutions include HCLL Transfusion and HCLL Donor, which address blood donor recruitment, blood processing, and transfusion activities for hospitals and medical centers; BloodSafe suite of hardware and software that enable healthcare facilities to store, monitor, distribute, and track blood products; LifeTrak software for blood centers; a nd BiologiCare, a bone, tissue, and cellular product tracking software. Its medication management products comprise WORx, a pharmacy information system to manage inpatient and outpatient pharmacy operations; MediCOE, a physician order entry module; MediMAR, a nurse point-of-care administration and bedside documentation module; MediREC, which assists in achieving compliance with a Joint Commission mandate; and pharmacy management and electronic prescribing systems. The company?s performance management products include InSight software that tracks performance metrics to assist healthcare managers to manage performance. It also provides software installation and maintenance services, as well as billing and collection services to home infusion and home/durable medical equipment markets. The company markets its products primarily through its direct sales force. Mediware Information Systems, Inc. was founded in 1970 and is headquartered in Lenexa, Kansas.

Advisors’ Opinion:

  • [By CRWE]

    Mediware Information Systems, Inc. (Nasdaq:MEDW) plans to acquire the assets of Indianapolis-based Strategic Healthcare Group LLC (SHG), a leading provider of blood management consulting, education and informatics solutions.

Hot Warren Buffett Stocks To Invest In 2014: Condoto Platinum NL (CPD)

Condoto Platinum NL, formerly Bailey Minerals NL, is an Australia-based mineral explorer. The Company is focused on exploring gold deposits in its Mt Palmer and Mallee Hen Point projects. Mt Palmer project consists of 21 hectares of the Mt Palmer mine covered by mining lease M77/406, which has an area of 0.21 square kilometers. The project encompasses the Mt Palmer mine within the Southern Cross district of Western Australia. The project comprises the Palmer’s Find Gold Mine. The Mallee Hen Point is an undrilled five kilometers strike gold anomaly in the Yamarna Greenstone Belt. It is located on the Cosmo Newbury Aboriginal Reserve in the Great Victoria Desert and consists of one granted exploration licence with an area of 70 square kilometers. In April 2010, the Company entered into farmin and joint venture agreements with Drake Resources Limited to explore for gold on the Mt Palmer and Mallee Hen Point projects. Advisors’ Opinion:

  • [By John Heinzl]

    Since April 1, the iShares S&P/TSX Canadian Preferred Share Index Fund (CPD) has dropped about 6.6%, excluding dividends. The fund is now yielding about 4.5%, up from 4.2% on April 1.

Hot Warren Buffett Stocks To Invest In 2014: Bombardier Inc (BDRAF)

Bombardier, Inc. is a Canada-based aerospace and transportation company. The Company operates in two segments: aerospace and rail transportation. The aerospace segment is structured by market segment (business aircraft, commercial aircraft and services), which is reflective of its organizational structure. The transportation segment is structured by market segment (rolling stock, services, system and signalling), which is reflective of its organizational structure, and by geographic region (Europe, North America, Asia-Pacific and Rest of world). As of December 31, 2012, the Company had 80 production and engineering sites in 26 countries, and a worldwide network of service centre. In May 2012, it launched the Learjet 70 and Learjet 75 aircraft programs. In October 2013, the Company announced that it has opened Bombardier’s new wing manufacturing and assembly facility in Belfast. In December 2013, the Company sold Flexjet’s activities to Flexjet, LLC. Advisors’ Opinion:

  • [By Adam Levine-Weinberg]

    Yet there is a fourth major competitor in the commercial aircraft market — Bombardier (NASDAQOTH: BDRAF  ) — and it has its own advanced-technology airplane. The company’s CSeries plane is expected to make its first flight as early as this week. Yet the CSeries put up a goose egg at the Paris Air Show, failing to notch a single order. While Bombardier has nearly 200 firm orders for the CSeries, the company will rapidly burn through that backlog once it starts CSeries mass production.

Hot Warren Buffett Stocks To Invest In 2014: Camtek Ltd (CAMT)

Camtek Ltd. (Camtek), incorporated in 1987, designs, develops, manufactures and markets automated solutions dedicated for enhancing production processes and yield for the semiconductor manufacturing and packaging and the printed circuit board (PCB) and integrated circuit (IC) substrate industries. Camtek also designs, develops, manufactures and markets automated optical inspection (AOI), systems and related products. The Company’s AOI systems are used to enhance both production processes and yields for manufacturers in the semiconductor manufacturing and packaging industry and PCB and IC Substrate industry. Through the acquisition of Printar’s assets, it also engaged in developing, manufacturing, sale and marketing of direct digital material deposition systems and inks for the PCB industry, with two major fields of activity: Solder Mask and Legend. In addition, through the acquisition of Sela, it is also engaged in the development, manufacturing and marketing of automate d scanning electron microscope (SEM) and transmission electron microscope (TEM) sample preparation equipment, primarily for the semiconductor industry.

As of December 31, 2011, the Company had sold more than 2,500 AOI systems in 34 countries worldwide. The Company’s PCB customer base includes the majority of the 100 PCB manufacturers worldwide. As of December 31, 2011, it had sold over 300 Falcon systems to more than 25 semiconductor manufacturers, among them outsourced semiconductor assembly and test (OSAT), integrated device manufacturers (IDM) and wafer level packaging subcontractors, including eight out of the top 10 semiconductors companies.

Camtek’s AOI systems consist of an electro-optical assembly unit, either movable or fixed, which consists of a video camera, precision optics and illumination sources. The electro-optical unit captures the image of the inspected product; a precise, either movable or fixed table, that holds the inspected product, and an electronic hardware unit, which operates the! entire system and includes embedded components that process and analyze the captured image by using its algorithms. Its systems can also compile and communicate statistical reports of inspection findings through the customer’s factory information system. The Company offers a range of systems for automated optical inspection of semiconductor wafers, IC substrates and PCBs. These systems are used to enhance production yields and assist in controlling manufacturing processes at wafer fabrication, test and assembly houses, and PCB plants worldwide.

The Company’s Falcon systems are designed for the back end market of the semiconductor industry. The Falcon’s advanced algorithms and inspection capabilities enable its dedicated models to detect defects in the die, which, if left undetected, may cause failure. The Condor is designed to meet the current and future inspection needs of the semiconductor industry. The Condor, through algorithms and advanced hardware configuration, is designed to enhance two dimensional (2D) and three dimensional (3D) detection abilities and increased throughput. The Condor family includes models for: 3D and 2D metrology and inspection of bumped-wafer prepared for packaging in the flip-chip technology; 2D metrology and inspection of finished wafers at the end of their manufacturing process and in test houses; Post-dicing inspection of frame-mounted wafers at assembly and packaging facilities, where it adds the value of detecting dicing-related damage, and inspection and metrology of micro-electro mechanical systems (MEMS) and other special applications.

Condor 5LED is an AOI system designed to provide solutions to a range of requirements that are to light emitting diode (LED) semiconductor manufacturers. The LED market’s special inspection requirements are characterized by 3-6 inch wafers, each of which may contain between 100 to over 200 thousand LED devices per wafer. Typically, the wafe r is made of a translucent compound semiconductor, such as g! allium ar! senide, gallium phosphide and/or indium phosphide. The Gannet system is designed for the front end market of the semiconductor industry.

The Company’s AOI products for this industry consist of five product lines: the Phoenix, Dragon and Orion for the inspection of inner and outer layers of PCB panels and ultra-fine-line IC substrate; large area masks (LAM) dedicated for inspection of artwork; and the Pegasus for final inspection (AFI) of IC substrates and high density interconnect (HDI) panels. The Phoenix product family, introduced in November 2011, is designed to support a range of the demanding PCB and IC substrate applications, while keeping in pace with the dynamic technology changes in the industry. The Phoenix product family is enhanced with Spark – Camtek’s and detection engine providing high detection capabilities, while minimizing false calls.

Dragon systems are high-throughput, automation-ready systems for inspection of all PCB types i n a mass production environment. Dragon models are optimized for specific PCB technology ranges – from mainstream circuits of typically 100 (microns) conductor line width, up to high density substrates having 12 (microns) wide conductive lines. All Dragon models are designed to interface with automated material handling mechanisms provided by the Company or other automation suppliers. Orion systems are stand-alone AOI systems for high volume inspection of all PCB types designed to operate in inspectify mode of operation. Inspectify is a mode of operation enabling the operator to perform verification immediately after inspection on the same system, thus saving time and eliminating handling-related defects.

LAM is specially designed for main-stream LAM inspection. It offers unparalleled detection ability on LAM with down to 25 (microns) line/space width technology. The LAM incorporates advanced technology innovations to ensure the level of detection that these ma sks require at this critical production stage. Camtek offers! various ! stand-alone verification systems that enable verification of panels after inspection. The Pegasus line includes systems for automated inspection of finished IC substrates that are subsequently used in packaging of ball grid array (BGA) and Chip Scale Package (CSP) devices. The Pegasus inspects both sides of the substrate, detecting process and mechanical defects, in particular in the gold-plated areas, where the substrate will interconnect with the silicon die or the PCB, and in the solder-mask areas. Pegasus models handle substrates in strip format in magazines.

GreenJet is a SM digital printing system aimed to replace the conventional SM application lines for prototypes and high mix low volume production. The GreenJet system offers manufacturers flexible and digital SM printing technology solution. The LGP system incorporates PCB digital legend printing technologies with specially developed heat curable ink, resulting in output and system performance. Camtek h as developed the inks for both LGP and GreenJet, which involves different chemicals mixed together in order to reach the required ink characterization.

The Company competes with Rudolph Technologies Inc., KLA-Tencor Corporation, Topcon Corporation, Toray Industries, Inc., Hitachi Ltd., Nidec Tosok Corporation., FEI Company, SII Nanotechnology Japan, Carl Zeiss, Inc., Orbotech Ltd., Dainippon Screen Manufacturing Company, Lloyd-Doyle Limited, Gigavis Co. Ltd., ATI Electronics Pty Ltd., Shirai Electronics Industrial Co. Ltd., First EIE SA and MicroCraft K.K.

Advisors’ Opinion:

  • [By James E. Brumley]

    In retrospect, their pullbacks come as no real surprise. Neither Voxeljet AG (NYSE:VJET) nor Camtek LTD. (NASDAQ:CAMT) saw their shares soar on any news that was meaningfully sustainable, and after the “shoot first, ask questions later” market had a chance to start asking questions, it became clear that – even with the largest of glimmers of corporate progress unveiled a few weeks ago – CAMT and VJET both had been bid up more on hype and less on substance. Meanwhile (and this could be bitterly ironic to some), a small cap play in the same 3D printing space that (1) didn’t beat the daylights out of its hype-drum, and (2) is actually much closer to bringing a revenue-bearing product to the market [per today’s news – more on that below] isn’t getting anywhere near the same attention. That company? Makism 3D Corp. (OTCBB:MDDD). The good news is, MDDD finally looks like it’s revving its engine, while Camtek and Voxeljet AG shares continue to deteriorate.

  • [By James E. Brumley]

    Investors who’ve made a point of keeping tabs on the 3D printing craze this year will know that a pair of small caps in this space – Camtek LTD (NASDAQ:CAMT) and Voxeljet AG (NYSE:VJET) – have dominated the headlines in just the past few weeks. For CAMT, the big news was the recent announcement that it would be the first 3D printer maker to develop a product that could print circuit boards. As for VJET, news that it was going to greatly expand its on-demand-printing capacity (for customers that need smaller occasional jobs but don’t want to buy a printer of their own) lit the stock up quite nicely.

  • [By Paul Ausick]

    Stocks on the Move: Ingersoll-Rand is down 22.2% at $55.54 after completing a spin-off of Allegion plc. Canadian National Railway Co. (NYSE: CNI) is down 48.6% at $57.78 following a 2-for-1 stock split. Camtek Ltd. (NASDAQ: CAMT) is up 38.9% at $5.71.

  • [By Paul Ausick]

    Shares of tech industry testing and inspection systems maker Camtek Ltd. (NASDAQ: CAMT) closed at $1.89 on November 7th, the day the company announced third-quarter earnings. It closed at $2.65 last Friday and skyrocketed to a high of $6.43 on Tuesday before dropping back to around $4.00 in Wednesday trading.

Hot Warren Buffett Stocks To Invest In 2014: Capital One Financial Corporation(COF)

Capital One Financial Corporation operates as the bank holding company for the Capital One Bank (USA), National Association (COBNA), and Capital One, National Association (CONA), which provide various financial products and services in the United States, the United Kingdom, and Canada. It offers consumer and small business credit card lending, national closed end installment lending, and the international credit card lending services. The company also provides various non-interest bearing and interest-bearing deposits, including demand deposits, money market deposits, negotiable order of withdrawal accounts, savings accounts, certificates of deposit, and other consumer time deposits. Its loan portfolio comprises credit card loans; consumer loans, such as auto, home, and retail banking loans; and commercial loans, including commercial and multifamily real estate, middle market, specialty lending, and small-ticket commercial real estate loans. In addition, the company provid es mortgage banking, treasury management, and depository services. It primarily serves consumers, small businesses, and commercial clients through branches, the Internet, and other distribution channels. The company was founded in 1993 and is headquartered in McLean, Virginia.

Advisors’ Opinion:

  • [By Holly LaFon]

    In the Financials sector, the Fund has significant investments (13.9% of Fund assets) in companies with a U.S. consumer banking focus (e.g., checking accounts, savings accounts, credit cards, home and personal loans). Capital One (COF), Wells Fargo (WFC), and Bank of America (BAC) are among the Fund’s largest positions within this category. While each company has diversified lines of business and derives its profitability from numerous customers, U.S. consumer banking has emerged as a dominant theme as a result of our bottom-up research process. For each investment opportunity, we consider the balance between company fundamentals (what we are buying) and valuation (what we are paying). The higher the valuation, the stronger the company fundamentals must be for us to invest. Although U.S. consumer banks are trading broadly in-line with their historical discount to the market, we believe that the quality of bank earnings today is superior to the quality of earnings ten years ago. After several years of intense regulatory scrutiny, most banks now have higher capital, better liquidity, fewer competitors, and the ability to improve profitability. In our opinion, banks could enter a period of loan growth, expanding margins, and positive operating leverage, while maintaining charge-offs below historical levels. Lastly, cyclical factors could work in their favor. For example, higher short-term rates and a steeper yield curve could increase the value of banks with low-cost deposits Capital One (the Fund’s largest position at 4.0%) is a consumer finance firm with credit card, auto lending, and banking businesses. The company has a strong franchise, attractive growth opportunities, and a disciplined management team with a solid track record and long-term focus. Capital One has grown market share while achieving high return on equity through its data analytics, which have led to sophisticated marketing and strong underwriting. Its acquisitions of ING Di rect and HSBC’s credi

  • [By Victor Selva]

    According to GuruFocus Real Time Picks, on Dec. 31 Brian Rogers (Trades, Portfolio) sold out his stake in Capital One Financial Corp. (COF). The Consumer Finance sector is dominated by three credit card companies: American Express (AXP), Discover Financial Services (DFS) and Capital One Financial. The business consists of charging small fees to consumer transactions. Although new legislation has arisen to protect consumers from credit card banks, I do not expect this to have a major impact on profitability. So what made Rogers cut back his position?

Hot Warren Buffett Stocks To Invest In 2014: Rigel Pharmaceuticals Inc.(RIGL)

Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, engages in the discovery and development of small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases. Its product development programs include R788, which completed a phase 2 clinical trial for the treatment of rheumatoid arthritis; and is in phase 2 clinical trials for B-cell lymphoma, T-cell lymphoma, immune thrombocytopenia purpura, and certain solid tumors. The company?s product development programs also comprise R343, which is in phase 1b clinical trial for the treatment of asthma. In addition, its preclinical programs include oral JAK3 inhibitor program for research in the area of immunology/inflammation; adiponectin mimetics for the treatment of type 2 diabetes mellitus and other potential indications; and muscle atrophy program for muscle homeostasis. Further, the company is evaluating R763/AS703569 compound in its aurora kinase inhibition program targeting cancer cell proliferation. Rigel Pharmaceuticals, Inc. has collaboration agreements with AstraZeneca AB; Pfizer, Inc.; and Daiichi Pharmaceuticals Co., Ltd. The company was founded in 1996 and is based in South San Francisco, California.

Advisors’ Opinion:

  • [By Sean Williams]

    What: Shares of Rigel Pharmaceuticals (NASDAQ: RIGL  ) , a clinical-stage small molecule drug company focused on inflammatory and autoimmune disorders, dropped as much as 21% after the company resumed full responsibility for its rheumatoid arthritis pill, Fostamatinib, and reported topline data from two late-stage studies involving the drug.

  • [By Max Macaluso, Ph.D.]

    Early Tuesday morning, Rigel Pharmaceuticals  (NASDAQ: RIGL  ) and its now-ex-partner, AstraZeneca (NYSE: AZN  ) , reported late-stage clinical trial results for the experimental rheumatoid arthritis drug Fostamatinib. In the following video, health-care analyst Max Macaluso discusses why Rigel dropped 18% after the news was released and the risks that lie ahead for Rigel Pharmaceuticals.

  • [By Keith Speights]

    Pain-medication pain
    Rigel Pharmaceuticals (NASDAQ: RIGL  ) experienced pain this week, resulting from its drug intended to help rheumatoid arthritis patients suffer less pain. Shares fell almost 23%.

  • [By Sean Williams]

    It wasn’t nearly as exciting a week for Rigel Pharmaceuticals (NASDAQ: RIGL  ) , which regained full rights to rheumatoid arthritis pill Fostamatinib from AstraZeneca on Tuesday. The pair actually reported a statistically significant ACR20 response rate at 24 weeks in two trials, but the data isn’t expected to be conclusive enough to gain FDA approval. AstraZeneca, not wanting to spend any more on the program, took a $140 million charge and returned all licensing back to Rigel. With the prospect of high trial costs and a drug which did well, but perhaps not well enough to compete with competition already on the market, Rigel is now in a tough position and is worth avoiding at all costs.

Hot Warren Buffett Stocks To Invest In 2014: The Hackett Group Inc.(HCKT)

The Hackett Group, Inc. operates as a strategic advisory and technology consulting firm primarily in the United States and western Europe. The company offers executive advisory programs, benchmarking, business transformation, and technology consulting services, as well as shared services, offshoring, and outsourcing advice. Its executive advisory programs consists of advisor inquiry, an inquiry service used by clients for access to fact-based advice on proven approaches and methods to increase the effectiveness of selling, general, and administrative processes (SG&A); best practice research, a research that provides insights into the proven approaches in use at organizations; peer interaction program comprising member-led Webcasts, annual Best Practice Conferences, annual Member Forums, membership performance surveys, and client-submitted content; and best practice intelligence center, an online, searchable repository of practices, performance metrics, conference presentat ions, and associated research. The company?s bench marking services conduct studies in the areas of SG&A, finance, human resources, information technology, procurement, enterprise performance management, shared service centers, and working capital management. These services are used by clients to establish priorities, generate organizational consensus, align compensation to establish performance goals, and develop the required business case for business and technology investments. Its business transformation programs help clients to develop coordinated strategy for achieving performance improvements across the enterprise; and Hackett Technology Solutions help clients choose and deploy the software applications that meet their needs and objectives. The company was formerly known as Answerthink, Inc. and changed its name to The Hackett Group, Inc. in January 2008. The Hackett Group, Inc. was founded in 1991 and is headquartered in Miami, Florida.

Advisors’ Opinion:

  • [By ValueArtifex]

    One such situation currently in the process of unfolding this month is a Dutch Tender by The Hackett Group (HCKT). I will briefly discuss the underlying business, what exactly a Dutch Auction (or in this case, a Tender) is, what options investors have when approaching this situation and how it could play out.

Hot Warren Buffett Stocks To Invest In 2014: Opt-Sciences Corp (OPST)

Opt-Sciences Corporation, incorporated on November 1956, conducts its business through its wholly owned subsidiary, O and S Research, Inc. The Company deposits anti-glare and/or transparent conductive optical coatings on glass used primarily to cover instrument panels in aircraft cockpits. It also provides full glass cutting, grinding and painting operations, which augment its optical coating capabilities. Its products are designed to enable pilots to read aircraft instruments in direct sunlight or at night or in covert situations using appropriate night vision filters or to protect the instruments from electromagnetic interference. The Company’s business is dependent on a robust commercial, business, and regional aircraft market and to a lesser degree the military aircraft market. It generally has a four to twelve week delivery cycle depending on product complexity, available plant capacity and required lead time for specialty raw materials, such as polarizers or filter glass.

The Company’s offers incorporate an optical coating of some type. Its primary coatings are for aircraft cockpit display applications and consist of its anti-reflection coating used for glare reduction and its transparent conductive coating used for electromagnetic interference shielding. In addition, it also offers a full range of other specialty instrument glass, including night vision filter glass, circular polarizers, touchpads, glass sandwiches for liquid crystal displays (LCDs) as well as other custom designed specialty glass components and assemblies. It uses its technology to apply a micro thin optical non-glare and/or conductive coating to the glass. Both processes utilize the deposit of a thin film of metal or metal oxide on the surface of the glass. The process takes place in a heated vacuum chamber. It heats the deposited material to over 1800 degrees Centigrade causing it to evaporate.

The Company competes with JDSU, Mod A Can , Dontech, Schott Glass and Hoya Optics

Advisors’ Opinion:

  • [By Geoff Gannon] ng>Micropac

    Micropac is 76% owned by Heinz-Werner Hempel. He’s a German businessman. You can see the German company he founded here. He’s had control of Micropac for a long-time. I don’t have an exact number in front of me. But I would guess it’s been something like 25 years.

    ADDvantage

    ADDvantage Technologies is controlled by the Chymiak brothers. See the company’s April 4 press release explaining their decision to turn over the CEO position to an outsider. Regardless, the Chymiaks still control 47% of the company. Ken Chymiak is now chairman. And David Chymiak is still a director and now the company’s chief technology officer. Clearly, it’s still their company.

    By the way, the name ADDvantage Technologies has nothing to do with the Chymiaks. Today’s AEY really traces its roots to a private company called Tulsat. The Chymiak brothers acquired that company about 27 years ago. So, effectively, when you buy shares of AEY you are buying into a 27-year-old family-controlled company.

    That’s pretty typical in the world of net-nets.

    Solitron

    Solitron Devices is 29% owned by Shevach Saraf. He has been the CEO for 20 years. The post-bankruptcy Solitron has never known another CEO. Before the bankruptcy, Solitron was a much bigger, much different company. So even though we are not talking about the founder here – and even though 70% of the company’s shares are not held by the CEO – we’re still talking about a company where one person has a lot of control. Solitron only has three directors. Saraf is the chairman, CEO, president, CFO and treasurer. Neither of the other two directors joined the board within the last 15 years. So, we aren’t talking about a lot of tumult at the top.

    In fact, profitable net-nets seem to be especially common candidates for abandoning the responsibilities of a public company without actually getting taken private.

    OPT-Sciences

    This company i s controlled by Arthu

Hot Warren Buffett Stocks To Invest In 2014: Moog Inc (MOGA)

Moog Inc. (Moog), incorporated on August 1, 1951, is a designer, manufacturer and integrator of precision motion and fluid controls and systems for a range of applications in aerospace and defense and industrial markets. The Company operates in five segments: Aircraft Controls, Space and Defense Controls, Industrial Systems, Components and Medical Devices. Within the aerospace and defense market, its products and systems include military and commercial aircraft flight controls, thrust vector controls for space launch vehicles, controls for gun aiming, stabilization and automatic ammunition loading for armored combat vehicles, satellite positioning controls and controls for steering tactical and strategic missiles. In July 2012, it acquired American Pacific Corporation’s In-Space Propulsion business. In August 2012, the Company acquired Tritech International Limited. In January 2013, the Company acquired Broad Reach Engineering Company. Effective March 21, 2013, the Company acquired Aspen Motion Technologies Inc. In July 2013, Moog Inc completed the sale of its Buffalo, New York operations of Ethox Medical to Dempsey Ventures.

Aircraft Controls

The Company designs, manufactures and integrates primary and secondary flight controls for military and commercial aircraft and provide aftermarket support. The Company systems are used in commercial transports, supersonic fighters, multi-role military aircraft, business jets and rotorcraft. The Company also supply ground-based navigation aids. During the fiscal year ended September 29, 2012 (fiscal 2012). The Company is working on several development programs, including the F-35 Joint Strike Fighter, Boeing 787 Dreamliner, COMAC C919, Airbus A350XWB, several business jet programs and a new military air refueling tanker KC-46. The F-35 flight test phase has expanded covering three variants and initial production is increasing with aircraft being delivered to international partn ers. The Company’s military production programs include th! e F/A-18E/F Super Hornet, the V-22 Osprey tiltrotor, the Black Hawk/Seahawk helicopter and the F-35. The Company’s commercial production programs include the full line of Boeing 7-series aircraft, Airbus A330 and a range of business jets.

The Company competes with Parker Hannifin, UTC (Goodrich, Hamilton Sundstrand), Liebherr, Nabtesco, Woodward Governor and Curtiss-Wright.

Space and Defense Controls

Space and Defense Controls provides controls for satellites and space vehicles, launch vehicles, armored combat vehicles, tactical and strategic missiles, security and surveillance and other defense applications. For commercial and military satellites, The Company design, manufacture and integrate propulsion systems and components (attitude control and orbit insertion) and actuation systems and components for deploying solar panels and antennae pointing. The Atlas, Delta and Ariane launch vehicle programs use its steering and propulsion controls. The Company is also developing products for NASA’s new Space Launch System.

The Company designs and builds steering and propulsion controls for tactical and strategic missile programs, including Hellfire, TOW and Trident. The Company supply valves and steering controls on the U.S. National Missile Defense Agency’s Ballistic Missile Defense initiative. The Company designs and manufactures systems for gun aiming, stabilization, turrets, automatic ammunition loading and driver vision enhancement on armored combat vehicles for a range of international and United States customers. The Company designs, builds and integrate stores management systems for light attack aerial reconnaissance platforms. The Company also designs and builds high power, quiet controls for naval surface ship and submarine applications.

The Company competes with Honeywell, Parker Hannifin, Vacco, Valvetech, Marotta, SABCA, ESW, Aerojet, Snecma, Valcor, Aeroflex, UTC (Ha milton Sundstrand), Limitorque, Sargeant Industries, RVision! , Directe! d Perception, ATA Engineering, CDA InterCorp, RUAG, Rockwell Collins, Woodward Governor, Sierra-Nevada, Vicon, Videotec and Lord Corp.

Industrial Systems

Industrial Systems serves a global customer base across a range of markets. For wind energy, Industrial Systems serves a global customer base across a variety of markets. For wind energy, The Company designs and manufactures electric pitch controls and blade monitoring systems for wind turbines. The Company supply electromechanical motion simulation bases for the flight simulation and training markets. For the plastics making machinery market, the Company designs, manufactures and integrates systems for all axes of injection and blow molding machines. For the test markets, the Company supply controls for automotive, structural and fatigue testing.

The Company supply electromechanical motion simulation bases for the flight simulation and training markets. In the power generation market , the Company designs, manufactures and integrates complete control assemblies for fuel, steam and variable geometry control applications. For the test markets, the Company supply controls for automotive, structural and fatigue testing. Metal forming markets use its systems to provide precise control of position, velocity, force, pressure, acceleration and other critical parameters. Heavy industry uses its high precision electrical and hydraulic servovalves for steel and aluminum mill equipment. Other markets include oil exploration, material handling, auto racing, carpet tufting, paper and lumber mills.

The Company competes with Bosch Rexroth, Danaher, Baumueller, Siemens, SSB, Parker Hannifin, Suzhou ReEnergy, MTS Systems Corp., Exlar and Hydraudyne.

Components

The Components segment’s product categories are slip rings, fiber optic rotary joints and motors. Slip rings and fiber optic rotary joints use sliding contacts and optical te chnology to allow unimpeded rotation while delivering power ! and data ! through a rotating interface. They come in a range of sizes that allow them to be used in many applications, including diagnostic imaging computed tomography (CT) scan medical equipment featuring high-speed data communications, de-icing and data transfer for rotorcraft, forward-looking infrared camera installations, radar pedestals, satellites, missiles, wind turbines, surveillance cameras and remotely operated vehicles and floating platforms for offshore oil exploration.

The Company’s motors are used in an equally range of markets, many of which are the same as for slip rings. Components designs and manufactures a series of fractional horsepower brushless motors that provide extremely low acoustic noise and reliable long life operation, with the market being sleep apnea equipment. Industrial markets use its motors for material handling and electric pumps. Military applications use its motors for gimbals, missiles and radar pedestals. Components’ other prod uct lines include electromechanical actuators for military, aerospace and commercial applications, fiber optic modems that provide electrical-to-optical conversion of communication and data signals, avionic instrumentation, optical switches and resolvers.

The Company competes with Danaher, Allied Motion, Ametek, Woodward MPC, Axsys, Schleifring, Airflyte, Smiths, Kearfott and Stemmann.

Medical Devices

Medical Devices segment operates within four medical devices market areas: infusion therapy, enteral clinical nutrition, sensors and surgical hand pieces. For infusion therapy, its primary products are electronic ambulatory infusion pumps along with the associated administration sets. Applications of these products include hydration, nutrition, patient-controlled analgesia, local anesthesia, chemotherapy and antibiotics. The Company manufactures and distributes a complete line of portable pumps, stationary pumps and disposable sets that ar e used in the delivery of enteral nutrition for patients in ! their own! homes, hospitals and long-term care facilities. The Company manufactures and distributes ultrasonic and optical sensors used to detect air bubbles in infusion pump lines and ensure accurate fluid delivery. The Company’s surgical hand pieces are used to safely fragment and aspirate tissue in common medical procedures such as cataract removal.

The Company competes with B. Braun, CareFusion, Smiths Medical, Hospira, Alcon, Baxter International, CME, I-Flow, Covidien, Etalon, Introtek and Ross (Abbott).

Advisors’ Opinion:

  • [By Seth Jayson]

    Moog (NYSE: MOGA  ) reported earnings on April 26. Here are the numbers you need to know.

    The 10-second takeaway
    For the quarter ended March 30 (Q2), Moog met expectations on revenues and beat expectations on earnings per share.